Tumor-specific PI3K inhibition via nanoparticle targeted delivery in head and neck squamous cell carcinoma

被引：0
|
作者：
Mizrachi, Aviram
Shamay, Yosi
Shah, Janki
Brook, Samuel I.
Soong, Joanne
Rajasekhar, Vinagolu K.
Humm, John L.
Powell, Simon N.
Baselga, Jose
Heller, Daniel A.
Haimovitz-Friedman, Adriana
Scaltriti, Maurizio
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4122
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4122
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Use of tumor-specific T-cell lines for definition of immune responses to squamous cell carcinoma of the head and neck
    Whiteside, TL
    Okada, K
    Chikamatsu, K
    HEAD AND NECK CANCER, VOL 4, 1996, : 516 - 523
  • [32] MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck
    Luangdilok, Sutima
    Box, Carol
    Harrington, Kevin
    Rhys-Evans, Peter
    Eccles, Suzanne
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (04) : 520 - 529
  • [33] Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384
    Leiker, Andrew J.
    DeGraff, William
    Choudhuri, Rajani
    Sowers, Anastasia L.
    Thetford, Angela
    Cook, John A.
    Van Waes, Carter
    Mitchell, James B.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2792 - 2801
  • [34] EGFR/PI3K/AKT/MTOR PATHWAY IN HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENTS WITH DIFFERENT HPV STATUS
    Janecka-Widla, Anna
    Majchrzyk, Kaja
    Mucha-Malecka, Anna
    Biesaga, Beata
    POLISH JOURNAL OF PATHOLOGY, 2021, 72 (04) : 296 - 314
  • [35] Integrative drug sensitivity analysis of PI3K/mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Zhang, Ming
    Saigal, Rishi
    Byers, Lauren A.
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2015, 75
  • [36] A Comprehensive Evaluation of Biomarkers Predictive of Response to PI3K Inhibitors and of Resistance Mechanisms in Head and Neck Squamous Cell Carcinoma
    Mazumdar, Tuhina
    Byers, Lauren A.
    Ng, Patrick Kwok Shing
    Mills, Gordon B.
    Peng, Shaohua
    Diao, Lixia
    Fan, You-Hong
    Stemke-Hale, Katherine
    Heymach, John V.
    Myers, Jeffrey N.
    Glisson, Bonnie S.
    Johnson, Faye M.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (11) : 2738 - 2750
  • [37] Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384
    Leiker, A.
    DeGraff, W.
    Choudhuri, R.
    Sowers, A. L.
    Thetford, A.
    Cook, J. A.
    Van Waes, C.
    Mitchell, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S196 - S197
  • [38] Antitumor activity of tipifarnib and PI3K pathway inhibitors in HRAS-associated head and neck squamous cell carcinoma
    Burrows, F.
    Shivani, M.
    Wang, Z.
    Chan, S.
    Gilardi, M.
    Gutkind, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S43 - S44
  • [39] HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines
    Elisabeth Foki
    Isabella Stanisz
    Lorenz Kadletz
    Ulana Kotowski
    Rudolf Seemann
    Rainer Schmid
    Gregor Heiduschka
    Wiener klinische Wochenschrift, 2021, 133 : 26 - 31
  • [40] HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines
    Foki, Elisabeth
    Stanisz, Isabella
    Kadletz, Lorenz
    Kotowski, Ulana
    Seemann, Rudolf
    Schmid, Rainer
    Heiduschka, Gregor
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 26 - 31
12345